Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

The elusive source of myofibroblasts: problem solved?

Fibrosis is omnipresent and contributes to a substantial proportion of all natural deaths. A recent study (pages 1262–1270) provides evidence that the mysterious perivascular cell, also known as the pericyte, is the cell type responsible for fibrotic disease in skin and skeletal muscle.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Mesenchymal perivascular cells are skin and muscle myofibroblast progenitors.

Katie Vicari

References

  1. Wynn, T.A. J. Clin. Invest. 117, 524–529 (2007).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Dulauroy, S., Di Carlo, S.E., Langa, F., Eberl, G. & Peduto, L. Nat. Med. 18, 1262–1270 (2012).

    Article  CAS  PubMed  Google Scholar 

  3. Zimmermann, K. Z. Anat. Entwicklungsgesch. 68, 29–36 (1923).

    Article  Google Scholar 

  4. Bruns, R.R. & Palade, G.E. J. Cell Biol. 37, 244–276 (1968).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Ross, R., Everett, N.B. & Tyler, R. J. Cell Biol. 44, 645–654 (1970).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Grillo, H.C. Ann. Surg. 157, 453–467 (1963).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Friedman, S.L., Roll, F.J., Boyles, J. & Bissell, D.M. Proc. Natl. Acad. Sci. USA 82, 8681–8685 (1985).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Kisseleva, T. et al. Proc. Natl. Acad. Sci. USA 109, 9448–9453 (2012).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Göritz, C. et al. Science 333, 238–242 (2011).

    Article  PubMed  Google Scholar 

  10. Humphreys, B.D. et al. Am. J. Pathol. 176, 85–97 (2010).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Hung, C., Linn, G., Duffield, J.S. & Schnapp, L. Am. J. Respir. Crit. Care Med. 185, A6805 (2012).

    Google Scholar 

  12. Armulik, A. et al. Nature 468, 557–561 (2010).

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jeremy S Duffield.

Ethics declarations

Competing interests

J.S.D. is on the scientific advisory board of Promedior, Inc. and Regulus Therapeutics. He holds stock options in Promedior, Inc. and receives research support from Regulus Therapeutics. He is also a consultant to Takeda Pharmaceuticals, Boehringer Ingelheim, Biogen Idec, GlaxoSmithKline, and Bristol-Myers Squibb.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Duffield, J. The elusive source of myofibroblasts: problem solved?. Nat Med 18, 1178–1180 (2012). https://doi.org/10.1038/nm.2867

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm.2867

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing